CDX2 and prostate cancer: Furthermore, He et al. found that CDX2 bound to the promoter region and inhibited miR-145-5p transcription, thus relieving the suppressive effect of miR-145-5p on the translation of small ubiquitin-like modifier protein-specific protease 1 and affecting the invasion and migration of prostate cancer cells [22].